Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Jul;59(7):613–617. doi: 10.1136/thx.2003.012047

Inflammatory related changes in bone mineral content in adults with cystic fibrosis

C Haworth 1, P Selby 1, A Webb 1, L Martin 1, J Elborn 1, L Sharples 1, J Adams 1
PMCID: PMC1747064  PMID: 15223873

Abstract

Background: Proinflammatory cytokines stimulate osteoclast activity and this could lead to increased bone resorption in patients with cystic fibrosis. The aim of this study was to determine whether markers of systemic inflammation are related to changes in bone mineral content (BMC) in adults with cystic fibrosis.

Methods: Total body BMC was assessed by dual energy x ray absorptiometry in 100 patients (54 male) of mean (SD) age 25.6 (7.1) years and forced expiratory volume in 1 second (FEV1) 61.8 (24.1)% predicted on recruitment to the study and 1 year later. Blood was also taken at these time points to measure markers of systemic inflammation.

Results: After 1 year BMC had reduced by 16.1 (62.1) g, p = 0.01; (0.6 (2.8)%). The change in BMC was related to mean levels of interleukin (IL)-6 (rs = –0.39, p<0.001) and C reactive protein (rs = –0.34, p = 0.002), intravenous antibiotic use (rs = –0.27, p = 0.006) and oral corticosteroid use (rs = –0.20, p = 0.045). Urinary markers of osteoclast activity were also related to IL-6 (rs = 0.27, p = 0.02). Multiple linear regression revealed that IL-6 (coefficient –2.2 (95% CI –3.4 to –1.0) per pg/ml, p = 0.001), colonisation with Burkholderia cepacia (coefficient –46.8 (95% CI –75.5 to –18.1), p = 0.002), and annual change in BMI (coefficient 15.4 (95% CI 3.6 to 27.2) per kg/m2, p = 0.011) were independently significant predictors of annual change in BMC.

Conclusions: These data suggest a pathophysiological mechanism by which chronic pulmonary infection results in bone loss in patients with cystic fibrosis.

Full Text

The Full Text of this article is available as a PDF (117.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aris R. M., Renner J. B., Winders A. D., Buell H. E., Riggs D. B., Lester G. E., Ontjes D. A. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med. 1998 Feb 1;128(3):186–193. doi: 10.7326/0003-4819-128-3-199802010-00004. [DOI] [PubMed] [Google Scholar]
  2. Aris R. M., Stephens A. R., Ontjes D. A., Denene Blackwood A., Lark R. K., Hensler M. B., Neuringer I. P., Lester G. E. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med. 2000 Nov;162(5):1674–1678. doi: 10.1164/ajrccm.162.5.2002100. [DOI] [PubMed] [Google Scholar]
  3. Bonfield T. L., Panuska J. R., Konstan M. W., Hilliard K. A., Hilliard J. B., Ghnaim H., Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111–2118. doi: 10.1164/ajrccm.152.6.8520783. [DOI] [PubMed] [Google Scholar]
  4. Conway S. P., Morton A. M., Oldroyd B., Truscott J. G., White H., Smith A. H., Haigh I. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000 Sep;55(9):798–804. doi: 10.1136/thorax.55.9.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elkin S. L., Fairney A., Burnett S., Kemp M., Kyd P., Burgess J., Compston J. E., Hodson M. E. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int. 2001;12(5):366–372. doi: 10.1007/s001980170104. [DOI] [PubMed] [Google Scholar]
  6. Grey A., Mitnick M. A., Shapses S., Ellison A., Gundberg C., Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct;81(10):3450–3454. doi: 10.1210/jcem.81.10.8855783. [DOI] [PubMed] [Google Scholar]
  7. Haworth C. S., Selby P. L., Horrocks A. W., Mawer E. B., Adams J. E., Webb A. K. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax. 2002 Aug;57(8):719–723. doi: 10.1136/thorax.57.8.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haworth C. S., Selby P. L., Webb A. K., Dodd M. E., Musson H., McL Niven R., Economou G., Horrocks A. W., Freemont A. J., Mawer E. B. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999 Nov;54(11):961–967. doi: 10.1136/thx.54.11.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ionescu A. A., Nixon L. S., Evans W. D., Stone M. D., Lewis-Jenkins V., Chatham K., Shale D. J. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):789–794. doi: 10.1164/ajrccm.162.3.9910118. [DOI] [PubMed] [Google Scholar]
  10. Knudson R. J., Lebowitz M. D., Holberg C. J., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983 Jun;127(6):725–734. doi: 10.1164/arrd.1983.127.6.725. [DOI] [PubMed] [Google Scholar]
  11. Kotake S., Sato K., Kim K. J., Takahashi N., Udagawa N., Nakamura I., Yamaguchi A., Kishimoto T., Suda T., Kashiwazaki S. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res. 1996 Jan;11(1):88–95. doi: 10.1002/jbmr.5650110113. [DOI] [PubMed] [Google Scholar]
  12. Manolagas S. C., Jilka R. L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995 Feb 2;332(5):305–311. doi: 10.1056/NEJM199502023320506. [DOI] [PubMed] [Google Scholar]
  13. Nixon L. S., Yung B., Bell S. C., Elborn J. S., Shale D. J. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1764–1769. doi: 10.1164/ajrccm.157.6.9704086. [DOI] [PubMed] [Google Scholar]
  14. Ott S. M., Aitken M. L. Osteoporosis in patients with cystic fibrosis. Clin Chest Med. 1998 Sep;19(3):555–567. doi: 10.1016/s0272-5231(05)70100-3. [DOI] [PubMed] [Google Scholar]
  15. Pollak R. D., Karmeli F., Eliakim R., Ackerman Z., Tabb K., Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998 Sep;93(9):1483–1490. doi: 10.1111/j.1572-0241.1998.468_q.x. [DOI] [PubMed] [Google Scholar]
  16. Romas E., Martin T. J. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int. 1997;7 (Suppl 3):S47–S53. doi: 10.1007/BF03194342. [DOI] [PubMed] [Google Scholar]
  17. Roodman G. D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., Smith J. F., Singer F. R. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992 Jan;89(1):46–52. doi: 10.1172/JCI115584. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES